Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[An experimental study on shock after temporary hepatic inflow occlusion and platelet activating factor (PAF)].

T Fukuoka1

  • 1First Department of Surgery, Nara Medical University, Kashihara, Japan.

Nihon Geka Gakkai Zasshi
|October 1, 1990
PubMed
Summary

Platelet activating factor (PAF) antagonists like CV6209 show potential in treating shock following liver occlusion. This study suggests PAF mediates injury, highlighting a therapeutic target for improving survival rates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nephrotoxicity and associated risk factors in patients treated with pemetrexed.

Die Pharmazie·2026
Same author

Bridging retraction method for robot-assisted surgery of rectal cancer-a video vignette.

Techniques in coloproctology·2024
Same author

Expression of Vincristin-induced Peripheral Neuropathy Related to Different Administration Methods.

Die Pharmazie·2022
Same author

Association between immune-related dermatologic adverse events and efficacy of pembrolizumab in non-small cell lung cancer patients.

Die Pharmazie·2021
Same author

Hyperkalemia in both surgically and medically treated patients with primary aldosteronism.

Journal of human hypertension·2017
Same author

Significance of adrenal computed tomography in predicting laterality and indicating adrenal vein sampling in primary aldosteronism.

Journal of human hypertension·2016

Area of Science:

  • Hepatology
  • Pharmacology
  • Shock Pathophysiology

Context:

  • Temporary hepatic inflow occlusion is a model for studying liver injury and shock.
  • Platelet activating factor (PAF) is implicated in inflammatory and vascular responses.
  • Understanding shock mechanisms after liver surgery is critical for patient outcomes.

Purpose:

  • To investigate the efficacy of CV6209, a PAF antagonist, in mitigating shock and improving survival after temporary hepatic inflow occlusion in rats.
  • To determine the role of PAF in the pathophysiology of shock induced by liver ischemia.

Summary:

  • Rats subjected to hepatic inflow occlusion were treated with CV6209 (PAF antagonist), heparin, or saline.
  • CV6209 administration improved 24-hour survival rates and reversed hypotension post-occlusion.

Related Experiment Videos

  • Reduced serum GOT elevation in the CV6209 group suggests protection against liver injury.

    • Impact:

    • PAF appears to be a key mediator in the shock and mortality associated with temporary hepatic inflow occlusion.
    • PAF antagonists represent a potential therapeutic strategy to manage shock in liver ischemia.
    • Findings contribute to the understanding of shock management in surgical interventions involving the liver.